Prophylactic effects of dexamethasone in lung injury caused by hyperoxia and hyperventilation

J Appl Physiol (1985). 1992 Apr;72(4):1320-5. doi: 10.1152/jappl.1992.72.4.1320.

Abstract

To determine if prophylactic corticosteroids would prevent acute lung injury caused by hyperoxia and barotrauma, 29 piglets (1.2 +/- 0.3 kg, 1-2 days of age) were studied. Ten piglets were hyperventilated [arterial PCO2 (PaCO2) 15-20 Torr] with 100% O2 for 48 h and compared with 10 piglets treated with the identical management but given 0.7 mg/kg of dexamethasone at time 0 and every 12 h for the 48-h study. Six piglets were normally ventilated (PaCO2 40-45 Torr) for 48 h with 21% O2 as an additional control group. Pulmonary function and tracheal aspirates were examined at time 0 and every 24 h. Bronchoalveolar lavage was performed for surfactant analyses at the conclusion of the study. In animals treated with hyperoxia and hyperventilation, lung compliance decreased 32% and tracheal aspirate polymorphonuclear leukocyte (PMN) chemotactic activity increased by 51%, cell counts by 204%, number of PMNs by 277%, elastase activity by 111%, and albumin concentration by 328% over 48 h (P less than 0.05). In contrast, dexamethasone-treated piglets had increases in only tracheal aspirate albumin concentration (206%) over the 48-h study. All cellular and biochemical variables were lower in dexamethasone-treated compared with hyperoxic hyperventilated piglets. Room air normal ventilation controls had only a 108% increase in tracheal aspirate albumin concentration noted. Despite quantitative differences in surfactant among the three groups, activity was unaffected. Results indicate that hyperoxia and hyperventilation for 48 h causes significant inflammatory changes and acute lung injury and that prophylactic high-dose dexamethasone significantly ameliorates this lung damage.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Animals, Newborn
  • Barotrauma / complications
  • Barotrauma / physiopathology
  • Dexamethasone / metabolism
  • Dexamethasone / pharmacology*
  • Hyperventilation / complications
  • Hyperventilation / physiopathology
  • Lung / drug effects*
  • Lung / physiopathology
  • Lung Injury*
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / pathology
  • Neutrophils / drug effects
  • Neutrophils / pathology
  • Oxygen
  • Pulmonary Surfactants / metabolism
  • Respiration, Artificial / adverse effects
  • Swine

Substances

  • Pulmonary Surfactants
  • Dexamethasone
  • Oxygen